Primary endocrine therapy should only be offered to women with oestrogen receptor (ER)-positive tumours who are ... http://t.co/bRTbzhQF5G
@UKCochraneCentr review finds surgery controls #breastcancer better than tamoxifen in older women but not survival http://t.co/LNjI4glXfs
Surgery controls #breastcancer better than tamoxifen in older women but doesn't extend survival http://t.co/LzZexOLymj #CochraneEvidence
Surgery controls #breastcancer better than tamoxifen in older women but doesn't extend survival http://t.co/LzZexOLymj #CochraneEvidence
Surgery controls #breastcancer better than tamoxifen in older women but doesn't extend survival http://t.co/LzZexOLymj #CochraneEvidence
Surgery controls #breastcancer better than tamoxifen in older women but doesn't extend survival http://t.co/LzZexOLymj #CochraneEvidence
Updated Cochrane Review: Surgery vs primary endocrine therapy for operable primary #breastcancer in elderly women http://t.co/tQ3CAV7JMz
Cirugía controla mejor que vs tamoxifeno el Ca mama en ♀ ≥70 años pero no amplía la supervivencia [Cochrane] http://t.co/IlQQppoK3I
Surgery controls breast cancer better than tamoxifen alone in older women but does not extend survival. Cochrane. http://t.co/cSxi7aRhK5
Surgery controls breast cancer better than tamoxifen alone in older women but does not extend survival. Cochrane. http://t.co/cSxi7aRhK5
Cirugía controla mejor que vs tamoxifeno el Ca mama en ♀ ≥70 años pero no amplía la supervivencia [Cochrane] http://t.co/IlQQppoK3I
Cirugía controla mejor que vs tamoxifeno el Ca mama en ♀ ≥70 años pero no amplía la supervivencia [Cochrane] http://t.co/IlQQppoK3I